Florida’s academic cancer centers are conducting innovative research that directly impacts patients by delivering new and promising cancer treatments. Leading-edge cancer research at the four centers ensures they provide patient care that meets the needs of Floridians and contributes to advancing scientific progress for future patients.
Read stories about the latest cancer research discoveries and innovative cancer treatment at Florida’s premier cancer centers.
Mayo Clinic Comprehensive Cancer Center
Mayo Clinic thoracic surgeons have begun using a single-port robotic system for surgeries that was recently cleared by the Food and Drug…
A neuro-oncologist at the Mayo Clinic reveals the telltale signs of a “classic brain tumor headache” and other brain tumor symptoms she looks for…
Rosa Rademakers, Ph.D., a neurogeneticist whose work at Mayo Clinic led to a landmark finding in neurodegenerative disease, has been awarded the 2026…
Moffitt Cancer Center
Researchers at Moffitt Cancer Center have played a key role in bringing new therapies from clinical trials to patients.
For students curious about science, medicine and the fight against cancer, Moffitt Cancer Center is offering more than just exposure. It is creating…
Moffitt Cancer Center will increase access to its world-class cancer care by expanding into Central Florida.
Sylvester Comprehensive Cancer Center
A new study published in JCI Insight identifies IL1RAP as an important driver of pancreatic cancer resistance and a promising therapeutic target.
For patients who do not respond as well to treatment, there are now new therapeutic options available, including innovative medications and highly…
Sylvester Comprehensive Cancer Center researchers traced how IDH-mutant gliomas evolve after treatment.
University of Florida Health Cancer Institute
Drs. Elias Sayour and Rowan Milner work with dog patients to develop treatments that may one day heal humans with brain and bone tumors.
A long-term study of nearly 900 childhood cancer survivors found that the heart-protective drug dexrazoxane significantly reduced…
Using an innovative technique, scientists discovered the first compound that effectively targets a protein that drives lung cancer.
